Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Nicox SA | EU:ALCOX | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.003 | -1.38% | 0.215 | 26,072 | 14:19:16 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.215 | 0.218 | 0.2185 | 0.215 | 0.217 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 7.14M | -20.88M | -0.4151 | -0.53 | 10.97M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 14:19:16 | 394 | 0.215 | EUR |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/11/2024 | 06:30 | UKREG | Nicox annonce la publication de la partie adaptive de l’étude clinique de.. |
| 19/11/2024 | 06:30 | UKREG | Nicox Announces Publication of the Adaptive Design Period of the NCX 470.. |
| 17/10/2024 | 05:30 | UKREG | Nicox : Point financier sur le troisième trimestre 2024 et résultats.. |
| 17/10/2024 | 05:30 | UKREG | Nicox Provides Third Quarter 2024 update and First Half 2024 Financial.. |
| 14/10/2024 | 05:30 | UKREG | Nicox et Soleus signent un accord de financement de 16,5 millions de.. |
| 14/10/2024 | 05:30 | UKREG | Nicox and Soleus Sign $16.5 million Royalty and Equity Financing |
| 23/9/2024 | 05:30 | UKREG | Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing.. |
| 23/9/2024 | 05:30 | UKREG | Nicox et Glaukos signent un accord exclusif de recherche incluant une.. |
| 18/9/2024 | 05:30 | UKREG | Nicox Announces Approval of ZERVIATE in China |
| 18/9/2024 | 05:30 | UKREG | Nicox annonce l’approbation de ZERVIATE en Chine |
Nicox (ALCOX) Share Charts1 Year Nicox Chart |
|
1 Month Nicox Chart |
Intraday Nicox Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
